Norbert Franz schrage

Dr. Norbert Franz schrage

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2005 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SRS. Rihawi
S. Rihawi
MFM. Frentz
M. Frentz
NSNorbert Franz schrage
Norbert Franz schrage

1 August 2001 in Burns
Verified
Journal Article
Closed access
NSNorbert Franz schrage
Norbert Franz schrage
BSBo Schloβmacher
Bo Schloβmacher
WAW Aschenbernner
W Aschenbernner
SLStéphanie Langefeld
Stéphanie Langefeld

15 May 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
NSNorbert Franz schrage
Norbert Franz schrage
MFM. Frentz
M. Frentz
FSF. Spoeler
F. Spoeler

1 December 2002 in Burns
Verified
Journal Article
Closed access
NSNorbert Franz schrage
Norbert Franz schrage
SKSirpa Kompa
Sirpa Kompa
WHWolfram Haller
Wolfram Haller
SLStéphanie Langefeld
Stéphanie Langefeld

21 July 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
NSNorbert Franz schrage
Norbert Franz schrage
MFMarkus Frentz
Markus Frentz
MRMartin Reim
Martin Reim
Purpose The Ex Vivo Eye Irritation Test (EVEIT) is used to analyse the clinical observations of corneal calcification attributed to the presence of phosphate within applied eye-drops used in treating glaucoma, Still–Chauffard syndrome, ocular burns and dry eyes. Method Live corneas from abattoir rabbit eyes were cultured in order to study epithelial healing following mechanical abrasion of the corneal surface combined with repeated exposure to various eye-drops. Results Obvious corneal calcification of the wound area along with a complete epithelial healing covering the calcified area was observed following exposure to phosphate hyaluronate eye-drops. Epithelial healing without calcification was achieved using citrate hyaluronate eye-drops. Conclusion Clinical observations show that topical use of artificial tears containing phosphate on injured eyes may lead to sight-threatening corneal complications. Simulation of such treatment conditions by the EVEIT convincingly demonstrates that changes in the composition of the pharmaceutically used treatments can prevent this undesired side effect. Although considerable healing was achieved during the repeated application of eye-drops, using either a phosphate or citrate buffer, only the drops containing citrate did not develop corneal calcification on the eye. The authors therefore recommend discontinuing the use of phosphate-buffered eye-drops, or other topically applied solutions, to avoid further injury to the patient.

30 May 2019 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
NWN. Wiesner
N. Wiesner
RDR. M. Dutescu
R. M. Dutescu
DUD. Uthoff
D. Uthoff
AKA. Kottek
A. Kottek
MRM. Reim
M. Reim
NSNorbert Franz schrage
Norbert Franz schrage
There is currently uncertainty about the most efficacious decontamination solution for corrosive chemical eye burns. This 30-year longitudinal study evaluated the relative efficacy of two different decontamination methods. Passive decontamination consists of rinsing with tap water, 0.9% normal saline, isotonic buffered phosphate solution, or Ringer’s lactate. Active decontamination adds an amphoteric, polyvalent, and chelating component with Previn® (Diphoterine®) solution (Laboratoire Prevor, Valmondois, France).